Current Report Filing (8-k)
03 10월 2020 - 12:25AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
September 30, 2020
RAYONT INC.
(Exact name of registrant as specified in
its charter)
|
Nevada
|
|
000-56020
|
|
27-5159463
|
|
(State or other jurisdiction of
incorporation or organization)
|
|
Commission file number
|
|
(IRS Employer
Identification No.)
|
Level 3, 26 Marine Parade, Southport
Queensland, 4215 Australia
+61 432 051 512
(Address, including zip code, and telephone
number, including area code,
of registrant’s principal executive offices)
14, Jalan Penguasa B U1/53B Temasya Glenmarie
40150 Shah Alam, Selaqngor, Malaysia
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
|
☐
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
☐
|
Soliciting
material pursuant to Rule 1 4a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
☐
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
☐
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange Act. ☐
Securities registered pursuant to Section 12(b)
of the Act:
|
Title of each class
|
|
Trading Symbol(s)
|
|
Name of each exchange on which registered
|
|
Common Stock, par value $0.001 per share
|
|
RAYT
|
|
OTC Markets Group
|
Item 1.01 Entry into a Material Definitive
Agreement.
On September 30,
2020,, pursuant to an Acquisition Agreement, Rayont Inc. (the “Company”), acquired all of the issued and outstanding
capital stock of Rayont International (L) Limited, a Malaysian company. The purchase price paid by the Company was 25,714,286
shares of its common stock valued at $1,800,000 or $0.07 per share, which was the closing price of the Company’s common
stock on the OTC Markets on September 29, 2020
Rayont
International (Labuan) Inc is an on offshore company incorporated in Labuan, Malaysia which offers attractive 3% tax on profit.
The company is clinical-stage life sciences company that holds the exclusive license for registering and commercializing PhotosoftÔ
technology for treatment of all cancers across Sub-Sahara
African region. The technology has been licensed in Australia, New Zealand, China, Malaysia and Sub-Sahara Africa. The human clinical
trial efforts have started in Australia and China conducted by Hudson Medical Institute, Australian.
The foregoing description of the Acquisition
Agreement does not purport to be complete and is qualified in its entirety by reference to the complete text of the document, which
is filed as an exhibit to this report and is incorporated herein by reference.
Item 7.01 Regulation FD Disclosure
On September 30, 2020, Rayont issued a press
release announcing the purchase of Rayont International (L) Limited, a Malaysian company. A copy of the press release is being
furnished as Exhibit 99.1 hereto and is incorporated into this Item 7.01 by reference.
The information furnished pursuant to Item
7.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act
of 1934, as amended, is not subject to the liabilities of that section and is not deemed incorporated by reference in any filing
of Basic’s under the Securities Act of 1933, as amended, unless specifically identified therein as being incorporated therein
by reference.
Item 9.01 Financial Statements and
Exhibits.
|
(a)
|
Financial Statements of Business Acquired.
The Registrant hereby undertakes to file
the financial statements if required by this Item 9.01(a) not later than 71 days after the date this Form 8-K was due for filing.
|
|
(b)
|
Pro Forma Financial Statements.
The Registrant hereby undertakes to file the
pro forma financial information if required by this Item 9.01(b) not later than 71 days after the date this Form 8-K was due for
filing.
|
(d) Exhibits
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
RAYONT INC.
|
|
|
|
|
|
Dated: October 2, 2020
|
By:
|
/s/ Marshini Thulkanam
|
|
|
|
Marshini Thulkanam
|
|
|
|
CEO and President
|
Rayont (CE) (USOTC:RAYT)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025
Rayont (CE) (USOTC:RAYT)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025
